DuPont Cuts Q3, Full-Year Outlook To Reflect Discontinued Ops; Sets Medium-Term Targets

DuPont (DD) has significantly lowered its third-quarter and full-year 2025 financial outlook, projecting Q3 net sales of $2.98 billion and adjusted EPS of $1.06, down from prior estimates of $3.32 billion and $1.15 respectively. The full-year 2025 net sales forecast was also reduced to $6.865 billion from a previous expectation of $12.85 billion, primarily due to the reclassification of its Aramids and Qnity businesses as discontinued operations ahead of their planned separations. Concurrently, the company set new medium-term targets through 2028, aiming for 3-4% organic sales growth CAGR and 8-10% adjusted EPS growth CAGR, alongside a 150-200 basis point improvement in operating EBITDA margin.

Analysis

DuPont de Nemours, Inc. has materially revised its financial outlook for the third quarter and full-year 2025, reflecting a significant strategic restructuring rather than a deterioration in core operations. The guidance reduction is a direct result of reclassifying its Aramids and Qnity (electronics) businesses as discontinued operations ahead of their planned separations. Specifically, Q3 2025 guidance for net sales was lowered to approximately $2.98 billion from $3.32 billion, while the full-year 2025 net sales forecast was nearly halved, dropping from $12.85 billion to $6.865 billion. This accounting change precedes the formal separation of the Qnity business, scheduled for November 1, 2025. To counterbalance the sharp decline in headline figures, management has issued new medium-term targets for the remaining company through 2028. These targets project a 3-4% compound annual growth rate (CAGR) in organic sales, an 8-10% CAGR in adjusted EPS, and a 150-200 basis point improvement in operating EBITDA margin, signaling a transition to a smaller, more focused entity with a clear growth and profitability trajectory.

Key Decisions for Investors

• Investors should re-evaluate DuPont's valuation based on the pro-forma financial profile of the remaining business, disregarding the headline guidance cut which is driven by divestitures.
• Focus on the newly issued medium-term targets, particularly the ability to achieve the 8-10% adjusted EPS CAGR and the 150-200 basis point margin expansion, as these are the key pillars of the future investment thesis.
• Anticipate near-term share price volatility as the market digests the dramatic reduction in top-line revenue, and monitor for successful execution of the planned business separations in Q3 and Q4 2025.
• It is now critical to analyze the profitability and growth prospects of the retained portfolio, as the company's future performance will depend entirely on these core assets post-separation.